Cargando…
Clinical Significance of Repetitive Compound Muscle Action Potentials in Patients with Myasthenia Gravis: A Predictor for Cholinergic Side Effects of Acetylcholinesterase Inhibitors
BACKGROUND AND PURPOSE: Acetylcholinesterase inhibitors (AChEIs) are widely used to treat myasthenia gravis (MG). Although AChEIs are usually tolerated well, some MG patients suffer from side effects. Furthermore, a small proportion of MG patients show cholinergic hypersensitivity and cannot tolerat...
Autores principales: | Lee, Hyo Eun, Kim, Yool-hee, Kim, Seung Min, Shin, Ha Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5063876/ https://www.ncbi.nlm.nih.gov/pubmed/27819419 http://dx.doi.org/10.3988/jcn.2016.12.4.482 |
Ejemplares similares
-
Clinical and Electrophysiologic Responses to Acetylcholinesterase Inhibitors in MuSK-Antibody-Positive Myasthenia Gravis: Evidence for Cholinergic Neuromuscular Hyperactivity
por: Shin, Ha Young, et al.
Publicado: (2014) -
Initial Repetitive Nerve Stimulation Test Predicts Conversion of Ocular Myasthenia Gravis to Generalized Myasthenia Gravis
por: Kim, Ki Hoon, et al.
Publicado: (2021) -
Repetitive Nerve Stimulation in MuSK-Antibody-Positive Myasthenia Gravis
por: Kim, Seung Woo, et al.
Publicado: (2017) -
Long-Term Safety and Efficacy of Tacrolimus in Myasthenia Gravis
por: Kim, Yool-hee, et al.
Publicado: (2019) -
Specific inhibition of acetylcholinesterase as an approach to decrease muscarinic side effects during myasthenia gravis treatment
por: Petrov, Konstantin A., et al.
Publicado: (2018)